The international coronavirus supply chain has become the latest target of cyber-espionage. The threat extends beyond pharmaceutical manufacturers to all of their suppliers and vendors, which provide potential points of entry for cyber thieves. In this conversation with SupplyChainBrain Editor-in-Chief Bob Bowman, Mike Hamilton, Chief Information Security Officer with CI Security, discusses what needs to be done to protect the entire vaccine supply chain from hackers.
For months, the World Health Organization has called on countries to come together to ensure a fair distribution of COVID-19 vaccines among rich and poor nations. Now it’s starting to lose patience.
Lindsey Conrad Kennedy, a labor and employment attorney with Eckert Seamans Cherin & Mellott LLC, lays out the legal framework under which employers can mandate that employees take the COVID-19 vaccine — with exceptions.
Food and drink companies continue to face significant carrier limitations, rising shipping costs and the challenge of integrating an omnichannel sales experience.
Global gaps in access to COVID-19 vaccines are raising concerns that the continued spread of the coronavirus will breed more dangerous versions of the pathogen, weakening medical weapons and further crippling economies.
Elaine Turner, a shareholder and partner in the law firm of Hall Estill, explains when employers can and cannot require their employees to take the COVID-19 vaccine when it’s available.
U.S. health officials are pleading for more use of COVID-19 antibody therapies from Eli Lilly and Co. and Regeneron Pharmaceuticals Inc. that have been plagued by logistical issues, lack of efficacy data and insufficient reimbursement.
The plan includes a wave of new spending, including more direct payments to households, an expansion of jobless benefits, more money for state and local governments and an expansion of vaccinations and virus-testing programs.
The U.S. government wants states to offer vaccines to millions more Americans as COVID-19 infections continue to soar, in a bid to bolster an immunization campaign that’s off to a rocky start.